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Introduction 
Because of the importance in abdominal surgery of finding 
an antibiotic or combinations of antibiotics which will be 
effective in suppressing the fecal flora, many workers have 
studied each new agent from this standpoint. Dearing and Heil-
man (7) found that oral administration of aureomycin would 
cause the disappearance of Gram negative or ganisms from the 
feces with the exception of Proteus and Pseudomonas. Cantor (4), 
Me t zger e t al (20), and r-1cVay (18 ) noticed a reduction of coli-
f orm bacteria in the feces during oral administration of aureo-
mycin. Metzger and Shapse (19) studied five hospital patients. 
Two of these with normal gastrointestinal tracts showed a r educ-
tion in the coliform count in from one to four days after the 
oral administration of aureomycin but there was a marked increase 
in the numbers of Proteus. The other three patients with func -
tioning colostomies ~howed no diminution of coliform organisms. 
In vitro s t udies of coliform bacilli by Frank , Wilcox and 
Finland (10) showed that 22 strains of E. coli were completely 
- --
inhibited by aureomycin at ).1- 25 ~g/ml and 2) s trains of Aero-
' 
bacter Aero.genes* were completely inhibited by 6.)- 200 pg/ml. 
*Aerobacter aerogenes is nov/ cl a ssified as Klebsiella (1)). 
The new terminology is being used in this paper. 
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Lund (16) found 91 per cent of Escherichia coli strains and 
97 per cent of Klebsiella strains studied sensitive to aureo-
mycin. Legler (14) studied )0 strains of Klebsiella and found 
that they were inhibited by 0.5-2.5 yg of aureomycin per ml. 
Schneierson ( 27) in a three-year study of bacterial sensi ti vi ty 
to aureomycin and chloramphenicol, noticed a tendency for !• coli 
to develop resistance. Szybalski and Bryson ())) using the 
gradient plate technique were able to isolate two strains of E. 
coli with simultaneous resistance to 15 antibiotics including 
aureomycin. Paine, Collins and Finland (21) tried unsuccessfully 
to make !· coli either aureomycin resistant. or dependent. 
Much of the \'rork with aureomycin has been carried out on 
animals. Edmiston et al (8), in evaluating several antibiot ics 
in dogs, found that orally administered aureomycin was no t very 
effective against peritonitis caused by fecal contamination at 
the time of operation. March and Biely (17) showed that feed 
containing aureomycin caused a reduction of coliform organisms 
in the feces of chicks. Schweinburg et al (28) administered 
aureomycin orally to dogs and found that coliform organisms 
completely disappeared from specimens of feces within two to 
eight days. 
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Statement of the Problem 
- -- _ _..;.._,.;;;.,~ 
Loh (15), in doing counts of organisms in the feces of 
normal humane during the oral administration of aureomycin, 
found a decrease in coliform bacteria in many of his subjects. 
This decrease was often followed by a rise to or above pre-drug 
level. The question arose - were resistant organisms emerging? 
In this paper sensitivity to aureomycin of the coliform organ-
isms of four of his subjects are presented. During the course 
of these studies, the coliform population in two subjects changed 
from Escherichia before therapy, to Klebsiella during or directly 
after treatment and back to Escherichia after the drug was 
stopped. In order to determine whether this might be a common 
change during aureomycin therapy, eight more persons were studied. 
Materials and Methods 
Subjects: '!he first series of subjects, A.P., K.c., A.C. 
and T.S., were people on whom Loh (15) had done extensive studies 
of fecal bacterial counts during oral aureomycin administration. 
'!hey were all adults and were essentially normal. 'Ihe fecal 
coliform organisms of these people were tested for sensitivity 
to aureomycin. '!he term •coliform• in this paper is used to 
include the two groups of organisms, Escherichia and Klebsiella. 
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The second series consisted of eight patients from the Home 
Medical Service of Boston University School of Medicine. These 
were all children ranging in ages from 6 months to 16 years. 
Sub j ects B. G. and M.C. had otitis media ; 14 .S. was a scar latina 
contact; P.J. had otitis media with acute tonsili tis ; A. C. had 
mump s; D.D. had measles and otitis media; E.L. had an up per res-
piratory infection; and L. was a probable measles contact. None 
of these patients had any gastrointestinal disor der. All received 
aureomycin orally in a dosage of 5 mg per pound of body weight 
per day. They had fecal examinations made previous to, during 
and after administration of the drug in order to observe any pos-
sible change in coliform organisms. 
Specimens: Fecal cultures from the first series were taken 
at irregular intervals throughout the studies. Three to fou~ 
cultures were taken before any treatment was started. 'Ihree to 
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five cultures were taken during the oral administration of aureo-
mycin and as many as possible were obtained after the drug was 
discontinued. The cultur e s , made by Loh, were received as violet 
red bile agar (Difco) pour plates. About 10 pink coliform colo-
nies ;-.rere picked from each day' a plates, inocula t ed onto nutri-
ent agar (Difco) slants, incubated overnight and held a t 4 C 
until sens i tivity t ests could be done. All colonies on plates 
''lith sparse gro1.,rth vrere p.cked. Some plates 1-.rere so overgrown 
'ITi th Proteus t1'1a t i t "'as almost i mpossible to isolate coliform 
bac t eria. Organisms from such plates v1ere picked to broth and 
streaked on Endo (Difco) plates repeatedly until the coliform 
organisms could be isolated in pure cul t ure. 
In the second series, spec imens 'llere obtained at the patients 1 
hm~es by rectal swab. The swab was placed in a tube contAining 
1 ml of buffered glycerol-saline solution*. The cultur e s were 
held in the refrigerator until they could be plated which was 
usually v:i thin 24 hours. 
*Buffered Glycerol-saline solution 
NaCl 
Dipotassium phosphate anhydrous 
~-~onop otassium phosphate anhydr-ous 
Glycerol 
Distilled water 
Add phenol red to i m?art pink color 
pH 8.0 
4. 2 gm 
).1 gm 
1.0 gm 
)00 ml 
700 ml 
The fecal material in the 1 ml of glycerol-saline solution 
was diluted 1:2 with sterile distilled water. Further dilutions 
of 1:18, 1:100, 1:1000 and 1:10,000 were made ;.lith sterile vlater. 
'!his 'tvide range of dilutions was found n:: cessary f"n order to have 
the colonies distributed on tl1e surface of the agar in numbers 
that could be counted on at least one plate. From some cultures 
the plate with 1:2 dilution sufficed, while from others the plate 
\'lith 1:10,000 contained so many colonies that counting was still 
rather difficult. The actual dilution was unimportant as long 
as the colonies were scattered over the surface of the plate so 
that the various kinds could be counted. In this \'lay their rela-
tive distribution could be observed. One-tenth rnl of the var i ous 
dilutions of a specimen wa s spread with a sterile bent gl as s rod 
on tergitol-7 (Difco) agar which contained 40 ml/L of 2, ;, 5-
triphenyl tetrazolium chlo1·ide (5, 6, ll, 55). Plates were 
incubated 16-18 hours and the different organisms tY'ere counted. 
On this medium Escherichia appeared as yellow, flat, rough, irreg-
ular colonies. Klebsiella colonies vmre smooth, raised, round 
and yellow with slightly pink centers. Late lactose and non-lac-
tose fermenting colonies t'iere red with a white periphery. These 
organisms reduced the triphenyl -tetrazolium chloride causing the 
colonies to become red. These colonies Here surrounded by a blue 
z~ne on this medium due to an alkaline reaction of the indicator, 
bromthymol blue. 
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From the first culture of each case ab out four colonies of 
Escherichia were picked and one each of any other colonies found. 
Ther eaf t er , one of each different type of colony was pi cked fro:11 
each cul ture . 'Ihese were transferred to semi-solid agar for 
mot ility testing and streaked on tergitol-7 agar to check purity . 
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The semi-solid agar \'las slightly modified from t~-a t used by Stuart ( 32 ). 
I t included 1% tryp tone, 3 gn of beef extract and 3.;5 gn of agar per 
liter. The cul t ures on semi-solid agar were held for further 
identification. 
Sensi ti vi ty te~s Th ::: aureomycin used \vas supplied in vials 
cont aining 20 mg of powdered aureomycin hydrochloride. The powder 
was dissolved within the vial by injecting 20 ml of sterile dis-
tilled water from a sterile syringe thr ough the rubber s t opper. 
This made a concentration of 1000 g of aureomycin per ml. The 
cont ents of the via l 't!ere withdrawn using the sa..me syringe and 
about 1.5 rn l were distributed int o ste r ile t es t tubes. These 
stock t ubes of aureomycin solution we1·e then quickfrozen in a 
mixture of dry ice and 95% alcohol. When fro zen they were stored 
at -20 0 unt il used. This frozen stock solut ion of aureomycin 
kept fo r several months stor ed in this manner. 
*The method of sensit ivi t y tes ting used is that employed in the 
Bacteriology Laboratory , rllassachusetts 'llemorial Hospital, Boston, 
"Mas sachuse tts. Aureomycin hydrochloride used for the sensitivity 
t ests was generously donated by the Antibio t ic Div ision of Chas. 
Pfizer & Oo., Inc., N.Y. 
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'Ihe frozen stock aureomycin wa s thawed di r ectly before use 
and dilu ted 1:10 vlith sterile distilled water thus giving a solu-
tion containing 100 g of aur eomyc in per ml. 
For each sensi t i vi t y t e st 11 t ubes were pla ced in a rack . 
0.5 ml of' s t erile brai n heart infusion broth (Difco) was pipett ed 
into all but the first tube. 0.5 ml of dilut ed aureomycin (100 
pg/ml) was t ransfer red to each of the fi r st two t ubes. 'Ihe solu-
t ion in t he second tube was thoroughly mixed and 0.5 ml of t he mix-
t ur e was added t o the third tube. This procedure was repeated 
ser ially in each tube until the tenth from which 0.5 ml was dis-
car ded aft e r the mixing . 'Ihe eleventh tube had no aureomycin and 
ser ved a s a con t rol of the culture. 
The culture was prepared by inoculating 2 ml of brain heart 
infusion br oth \'lith the culture to be tested. This was incubated 
6 
at )7 C for 6 hour s after wh i ch time it was diluted to 10 by 
p i pe tting 0.1 ml of the 6-hour culture int o 9.9 ml of sterile water, 
mixing , adding 0.1 ml of the mixture t o a second tube of 9 .9 ml 
of sterile water, mixing and adding 0 .1 ml of this to a t hird 
tube containing 9.9 ml of e~&rile brain heart infus ion broth. 
0.5 ml of' t he broth dilu tion of the culture \'las added to each of 
t he ten tubes of serially diluted aureomycin and to the eleventh 
tube of broth alone. Tnis gave ten tubes containing success i vely 
50 , 25, 12 .5, 6.25, ).12 , 1.56, 0 .78, 0.)9 , 0.19, and 0.09 pg of 
aureomycin per ml. 
After overnight incubation, the sensitivity tests were 
read. The least amount of aureomycin which resulted in no vis-
ible grm.,th was called the minimum inhibitory concentration 
(MIC) (9). 'lhis was considered the endpoint of the aensi t.ivi ty 
tests throughout this study. 
From one tube of frozen stock aureomycin eight cultures could 
be tested plus one control culture. The control organism was 
Bacillus cereuf11< and was se . up in the same manner as the coli-
form organisms being tested. 
9 
Identification of organisms: The: organisms isolated were 
identified by means of biochemical reactions. In the first series 
Russell's double sugar (Difco) for fermentation of glucose and 
lactose, semi-solid agar for motility testing, tryptophane broth 
for indol production, MR-VP medium (Difco) for methyl red test 
and acetyl-methyl carbinol production(Voges-Proskauer teat), and 
Simn:on 1 s citrate agar (Difco) were used. If organisms shov1ed an 
alkaline slant on Russell 1 s . double sugar, lactose fermentation 
was checked in broth. The trypto?hane broth cultures were tested 
for the presence of indol after four days of growth. !J.R-VP broth 
cultures were alloloJed to grow two days before testing . Alpha 
naphthol and 40% KOH were used in the Vogee-Proskauer teet. The 
four reactions, ind~ methyl red, Voges-Proskauer, and citrate 
•T~e control culture of B. cereus was received from the Bacterio-
logy Laboratory, Massachuset-ts Memorial Hospital, Boston, ·Massa-
chusetts. 
utilization, will be referred to hereafter by the mnemonic, 
I MV IO, devised by Parr (24). 
In the second series Kligle r 1 s medium (Difco) was used in 
place of Russell's double sugar. This enabled the observation 
of H2S production. Lactose broth was used with a ll organisms 
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of this series. Tne I~WIO reactions were carried out as des-
c r ibed before. All cultures in both series were incubated at 37 C. 
Terms used throughout this paper are as follows: E. coli 
was used to indicate an organism Vl'hich fermented lactose with 
the production of acid and gas within 24 hours at 37 0, was motile, 
non-mucoid and had n.wrc reactions of l.f--; Escherichia was used 
to denote any organism of this group which produced acid and gas 
rapidly from lactose and which did not have the other typical 
reactions of !· coli; e.g., HWIO 1/--, non-motile or HWIC Ii-I, 
motile; Klebsiella was used t~ indicate organisms which produced 
acid and gas in lactose broth within 24 hours at 37 C, were 
usually non-motile, frequently grew in mucoid colonies and had 
IMVIC reactions of --//. 
The term paracolon was used here much as it was defined by 
Borman, Stuart and \fueeler (2). It included those organisms which 
produced acid and usually g as from lactose after prolong ed incu-
bation, which ''lere usually motile and whose IMVIC reac tiona sho,ved 
any combination of results. 
Results 
Series 1 
The results obtained during study of the four subjects in 
th e first series are summarized in Table I. '!he data ehm'l t hat 
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in no case were the organisms resistant to the drug (See Table I). 
Ho v1ever, identificati on of the organisms isolated revealed marked 
changes in the coliform population. 
Subject l: Escher i chia disappeared comp letely from the feces 
of A.P. by the third day of aureomycin administration. These 
organisms were replaced by Klebsiella which remained until the 
third day after the drug was stopped. Then Escherichia reappeared 
and Klebsiella disappeared. Whereas all of the Escherichia strains 
isolated before the change showed the typical reactions of moti-
lity /, I~WIO 1/--, some of the organisms reappearing after aureo-
mycin administration were non-motile and of these some formed 
muc oid colonies. These two charac t eristics appeared together in 
six organisms; six others were non-motile only. None were mucoid 
only. 
Subject 2r ~· coli present in the feces of K.O. showed a 
much lees marked change than those in the feces of A.P. E. coli 
cont inued through the third day of aureomycin administration. 
According to Loh 1 s (15) counts, no coliform organisms were found 
during the last three days of t r eatment. Klebsiella and E. coli 
appeared together the day after the drug was discontinued. At no 
time was ~· coli completely replaced by Klebsiella as seen in A.P. 
Subject .2,: Tne feces of A.C. contained ~. coli with typical 
motili t.y and Il'>NIC Ctt--) reactions before, during , and after 
aureomycin administration. Klebsiella did not appear nor were 
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any cultural variants of Escherichia recovered. E. coli never com-
---
pletely vanished although on the third day of aureomycin adminis-
t ration only three colonies were present on the plate reC'e.tved. 
On the sixth and eighth days after cessation of the drug, only one 
and two colonies respectively could be picked from the original 
plat es. 
Subject 4: The las t sub ject, T.S., was somewhat differ ent 
f r om the outset. Escherichia isolated throughout study of this 
subject had typical I MVIO reactions of tt-- but v1ere all non-motile 
excep t one s train picked on the firs t day . Several late lac t ose 
and non-lactose fermenters which gave tt-- E~!IO r eactions were 
picked during the first five daya. One Klebsiella strain was 
isolated on the third day of aureomycin therapy, but Escherichia 
continued abundant. On the fifth day of aureomycin a dministration 
only one Escherichia colony could be picked but six paracolons 
were isolated. From the fifth day of therapy until the end of 
the study of this subjec t , which l asted only through the second 
day after aureomycin was withdrawn, Escher i chia isolat ed sho~tled 
Subject 
1. A.P. ! 
l 
TABLE I 
Summary of Aureo~cin Sensitivities of Organisms Isolated from Subjects 1 through 4 
Day 
1 l3 
2 l3 
3 l3 
1 D 
2 D 
4D 
.5 D 
6 D 
1 A 
2A 
3 A 
.5 A 
11 A 
13 A 
16 A 
19 A 
21 A 
23 A 
I 
I· 
I 
Escherichia (HIVIC f.f--, motile) 
Percentage of colonies 
Colonies at each MIC ~/rnl) 
isolated I 
0.78 1..56 3.12 6.2.5 
I 
I 
14 :86 14 0 0 
10 I o 90 10 0 
11 9 91 0 0 
10 0 80 20 0 
1 0 100 0 0 
1 0 100 0 0 
6* 0 33.3 66.7 0 
21* 19 62 14 .5 
10* 10 70 20 0 
10 0 50 50 0 
10* 20 6o 10 10 
6* 0 0 66.7 33.3 
4 0 25 .50 2.5 I 
Klebsiella (IMVIC --ff, non-motile) 
- - I Percentage of coloni·:-- -;otal 
Colonies 1 at each :t-UC ~/rnl) colonies 
isolated ! isolated 
7* 
11 
8 
7 
7 
8* 
:0.78 1.56 3.12 6.25 
I 
I 
i 0 
,18 
' 0 
I 
I 
0 
0 
0 
14 
9 
62.5 
14 
43 
37.5 
72 
27 
12 • .5 
72.5 
28 .5 . 
62.5 
14 
46 
2.5 
14 
28 5 . 
0 
14 
10 
11 
10 
1 
7 
11 
8 
7 
7 
10** 
10** 
21 
10 
10 
10 
10** 
4 
TA:BLE I continued 
Escherich!a (I~WIO ft--, motile) Klebsie1J.e, (I~WIC --ff, non-motile) 
. ----
Percentage of colonies Percentage of colonies Total 
Subject Day Colonies at each MIC ~/ml) Colonies at each MIO rp.g/ml) colonies 
isolated isolated isolated 
0.78 1.56 J.l2 6.25 0.78 1.56 .3.12 6.25 
1 B 10 4o .30 20 10 10 
2 B 10 l2o 4o 4o 0 10 
.3 B 10 110 90 0 0 10 5 B 10 20 70 10 0 10 
- 1D 7 0 71.5 28.5 0 7 
2. K.C. 2D 10 10 70 20 0 10 
3D 10 0 100 0 0 10 
lA 6 
.3.3-3 66.7 0 0 4 0 75 0 25 10 
2A 6 16.6 66 .7 0 1~.6 ! 4 0 0 0 100 10 
3 A 7 0 14 86 .3 0 0 66.7 .3.3-.3 10 
· SA 9 0 89 11 0 1 100 0 0 0 10 
8A 10 0 0 80 20 10 
Subject· Day 
1 :s 
2 :s 
3:8 
5 :s 
1 D I 
2 D I 
4D I 3- A.C. 5 D 
I 
lA 
2 A 
l 
3A 
5 A 
6 A 
8A 
10 A 
12 A 
TABLE I continued 
Escherichia (IMVIC tf--, motile) Klebsiella (nrvrc --fl., non-motile) 
l --- -,-Percentage of colonies Percentage of colonies Total 
Colonies at each MIC (y.g/ml) Colonies at each MIC (;lg/m1) coloni 
isolated isolated isolat 
0.78 1.56 3.12 6.25 0.78 1.56 3.12 6.25 
-
10 0 30 70 0 10 
10 0 0 100 0 10 
10 0 0 100 0 10 
10 0 0 80 20 10 
10 0 0 60 4o 10 
10 0 0 80 20 10 
3 0 0 66.7 33-J 3 
10 0 0 100 0 10 
I 
20 0 0 100 0 20 
10 0 JO 70 0 10 
7 0 0 43 57 7 
10 0 0 60 4o 10 
1 0 0 0 100 1 
2 0 0 50 50 I 2 
10 0 10 50 40 10 
9 0 33-3 44.5 22.2 9 
es 
ed 
1-' 
\Jl 
TABLE I continued 
' (IMVIC tf--, non-motile) Klebsiell~ (!~T IC --ft, motile) Escherichia 
- -
Percentage of colonies Percentage of colonies Total 
Subject D.ay Colonies at each MIC {y€,/rrll) Colonies at each MIC {pg/ml) coloni es 
isolated isolated isolated 
0.?8 1.56 ,3.12 6.25 0.78 1.56 ,3.12 6.25 
1 B 7 I 0 14 86 0 I 11** 2 B 9 0 11 89 0 11** 
.3 B 8 I 0 0 100 0 10** 
4B 9 1 0 11 89 0 10** 
1 D 11 ! o 45.5 54.5 0 I 12** 4. T.S. 2 D 10 0 10 90 0 ' 10 
.3 D 20 0 .30 6o 10 1 0 0 100 0 22** 
4D 8 0 12.5 8?.5 0 10** 
5 D 1# 0 100 0 0 7** 
6 D 8# 10 12.5 75 12.5 9** 
lA 11#: 9 91 0 1.3** I ~ I 2 A 10#= 0 100 0 10 
I I 
B Before administration of aureoJD¥cin; D During administration of aureoJD¥cin; A After admin-
istration of aureomwcin 
* A f ew colonies were both mucoid and non-motile or non-motile only. 
** Paracolon organisms included in the total number were disregarded. 
# All of these colon!es were mucoid. 
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mucoiC. colonies but with reactions s imilar to those of the oro-an-
"" 
i sms isola ted before treatment ; i.e., non-mot ile and 11-- U.!I!I C. 
In both the first and las t ca ses, A. P . and T.S., Pro t eus 
appeare d during administration of aureomycin and persisted after 
the drug wa s wi thdrawn . T.S. was Loh 1 sce.se vrhich developed 
Proteus vaginitis. 
Series 2 
As mentioned before, the shift of coliform organisms during 
the ora l administration of aureomycin, although it appeared in 
only two of four subjects and in only one of those to a marked 
degree, was unexpected and brought up the problem of how fre-
quently this occurred du rin,Q; aureomycin therap~.r . Spaulding et 
a l (31 ), in reporting five cases sho1~ed three 1-1hich had a s i milar 
change. Two of these r ece ived oral streptomyc in and one rec~ived 
a comb ination of streptomycin and sulfathalidine orally. 'The 
addi t ional e igh t subjects of Series 2 were s tudied to try t o shed 
more light on thi s aspect of aureomyc i n treatment. 
The outstanding feature of the second series was the variety 
of results obtained. Table II summarizes these resul t s. 
Subiects 2,, .§., 10, g, and 12. Initially t he coliforms 
found in the feces of B. G., P.J., A.D., D.D. and E.L. 1-rere pre-
dominate l y Escherich ia. Dur ing oral admi nistration of aureomycin 
there was a diminution in nun:bers or disappearance of this organ-
ism accompanied by the appearance of or an increase in numbers of 
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Klebsiella a nd/or paracolon organisms. After the drug was stopped, 
the relative nu:nbers of Escherichia increased al though no t nec-
essar ily to the or i g inal level. 
Typ i cal !· coli were isolated throughout the studies of 
the fecal specimens of three of the subjects , B.G. , P •• J. e.nd A.D. 
Non-mo t ile Escherichia \>Tere isolat ed fro rn the initial specimen 
of D.D. but t ypical, mot ile ~· coli were isolated from her last 
three specimens. Citrate utilizing Escherichia \>Te r e isolated 
throughout the study of E.L . However, this was accompanied by 
typical ~· coli i n t he l e. s t specimen ob tained after trea tment. 
Subiect I: From M.S . , unfortunately , no fecal swabs were 
obtained during the period of drug administration. 'fue two cul-
tures examined, one before and one a f t er aureomycin suggest the 
p o s sibility of a change similar to that mentioned above but insuf-
ficient data are availab le. 
Subjec t 6: M.C. showed 100 pe r c ent paracolon organi sms 
before, dur i ng and a f ter therapy . Although colonies which appeared 
s lightly different on the ter gi t ol-7 plates we r e isolated, they 
a ll showed the same biochecmical ree.ctions . If t ergitol-7 p lates 
..,.;ith e a ch organism were he l d fo r two to three day s, non-reducing 
colonies '"ould grow out of the reducing colonies. 
Sub i ec t .2_: L. showed a mix t u re of Es che r ichia, Klebsiella 
a nd paracolons from t he culture t aken before t reatment. 'Ihe cul-
ture te.ken durir.g aureomycin administration shmved an inc rease in 
Escherichia wi th a decrease in the o ther organi sms , j ust the oppo-
site to the change previousl:'Jr noted. After tres.tment the Escher-
ichia dropped to approximately the ori gina l level and the para-
colons increased and became the predo'!!inating ty-p e of organism. 
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Subject 
5. :B.G. 
(1)(3) 
6. M.C. 
(2) 
7. M.S. 
(1)(3) 
TABLE II 
Number and Percentage of Various Organisms Counted on Tergitol-7 Plates 
Subjects 5 through 12 
Esche;£ich;!.a* Klebsiella Miscellaneous 
Age Day 
~ 
(IMVIC --f7, non-motile) Organisms* 
No. N " No. fa o. jo 
1 :B 37 71 3 5 12 23 
6 mo lD 0 1 < 1 348 99 
6 D 0 26 6 398 94 
6A 0 4 2 230 98 
13 A 23 13 78 43 80 l.J4 
1 :B 0 0 117 100 
19 mo 2 D 0 0 244 100 
5 D 0 .o 243 100 
3A 0 0 261 100 
6 yr 1 :B 164 99 2 1 0 
2A 59 21 214 79 0 
1\) 
0 
Subject Age Day 
1 B 
8. P.J. 15 mo 6 D 
(1)(2) 11 A 
16 A 
1 B 
9. L. 16 yr 
2D 
(4) (2) 
2A 
1 B 
10. A.D. 7 yr 4D 
6D 
(1)(2) 
1A 
17 A 
T.AJ3LE II continued 
Escherichia* Klebsiella 
1& 
(IMVIC --tf, non-motile) 
No. No. % 
234 100 0 
158 59 110 40 
108 92 4 3 
112 69 50 31 
127 46 69 25 
258 96 8 ~ 
-" 
64 45 8 5 
119 100 0 
61 57 0 
12 48 0 
30 100 0 
92 100 0 
l-11 sc ellane ous 
Organisms* 
No. % 
0 
1 ( 1 
5 4 
0 
80 29 
1 <1 
68 49 
0 
45 43 
13 52 
0 
0 
1\) 
...... 
TABLE II continued 
Escherichia* 
Subject Age Day 
No. 7~ 
Klebsiella 
(I!.WIC --77, non-motile) 
No. % 
lHsc ella.neous 
Organisms* 
No. % 
11. D.D. 3 yr 
(5)(6) 
12. E.L. ~ yr 
(7)(2) 
1 ] 
1 D 
4D 
6 D 
23 A 
1 ] 
3D 
2A 
16 A 
200 
209 
200 
540 
506 
83 
1 
7 
329 
98 
54 
94 
81 
100 
2 
86 
2 
101 
9 
2 
0 
1 
0 
0 
5 
1 
25 
4 
<1 
1 
1 
82 
5 
120 
0 
92 
278 
365 
48 
1 
21 
2 
18 
52 
99 
98 
12 
] :Before administration of aureo~cin; D During administration of aureo~cin; A After 
administration of aureomycin 
* 
(1) 
(2) 
(J) 
(4) 
(5) 
(6) 
(7) 
Different kinds of organisms were isolated from cultures of different subjects. See 
reference numbers under subjects. 
Escherichia \orere typical ~. coli (IIIWIC f.f--, motile) 
Paracolons only 
Proteus arid paracolons · 
Typical~. coli (INVIC f./--, motile) and Escherichia (IMVIC -f.-.j., motile) 
:Before aureomycin - Escherichia (Il-NIC tf.--, non-motile) 
After aureo~cin - typical ~. coli (IMVIC ff.--, motile) 
Proteus, paracolons and Pseudomonas 
:Before aureo~cin - Escherichia (IMVIC ff-.f, motile) 
After aureomycin - the same organism plus t y-p ical ]}d. coli (IIviVIC 1-.f--, motile ) 
1\) 
1\) 
Discussion 
Coliform organisms from t he four subjects of Series 1 were 
tested fo r sensitivity to aureomycin . ~!inor differences vTere 
observed. 'Ihese did no t exceed a minimum inhibi tory concentra-
tion (MIO) of 0 .78-6.25 p g/ ml or four t ubes of the serial dilu-
tiona by the method used. 
Jackson and Finland (12) compared several techniques for 
testing the sens i tivity of bacteria to antibiotics. \'lide ranges 
of values vrere obtained for the !,1!0 of any one antibiotic for any 
given organism depending on the method used. Since the serial 
tub e dilution t echni que was used in the present work , a comp ari-
son with the work of others using a similar technique is made . 
Braude and Dockrill ( 3 ) found nine strains of ~· coli sen-
si tive to aureomycin in concentrations of 0.4-3.2 )-lg/ ml and 13 
strains of!· aerogenes (Klebsiel la) sensitive to 0.2-12.8 pg/ml. 
Bliss and Todd (1) found several strains of Escherichia suscepti-
ble to a !-..110 of 5 )lg of aureomycin per ml, several s t rains of 
Ae r obacter ( Klebsiella) susceptible to a MIO of 2.5-5pg/ ml and 
Klebsiella Pneumoniae A and B susceptib le to 1.25 and 5 pg/ ml 
respec t ively. \'/aisbren et al (34) studied different quantities 
of bac t eria in the inoculum of sensi tivi t \Y tests vii t h aureomycin. 
1 5 They found E. coli in nwllbers of approximately 1 x 10 to l x 10 
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was inhibited by 0.)8pg of aureomyc i n/ ml, 1 x 106 was inhibited 
by 1.5 )lg;/ ml and 1 x 107 inhibited by 3.1 pg/ml. The results 
obtained in the present study appear to lie within the range of 
sensitivities obtained by these workers. 
The minimum inhibitory concentration of aureomycin to 
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Escher ichia increased from 0 .78)Ug/ ml on the first day to 3.12 g/ 
ml at the end of the studies of A.P. and K.C. This 'iras a varia-
tion of three tubes of the serial dilutions. The control culture 
varied two tubes, MIG 0 .01-0.02 pg/ml from day to day. The varia-
tions in the results for cultures from the two subjects would 
ap pear at the mo st to be development of a minimal amount of resis-
tance. The MIC of 3.12 pg/ml of Escherichia isolated fro m A.C. 
and T.S. showed essentially no change. Toe I-':IC of Klebsiella 
organisms appeared t o be slightly higher than that of Escherichia 
but no resistance appeared to develop. 
Seven of t he 12 subjects showed a dec rease in Escherichia 
with an increase in other organisms during the oral administration 
of aureomycin. In four of the subjects the shift was toward 
Klebsiella. In three the shift was toward paracolon organisms. 
Paracolons w·ere not observed in two of the subjects of Series 1 
because only lactose fermenting organisms were studied. A few 
slo'fl lactose fermenters we re, hO\'rever, isolated from A.P. and 
T.S. of Series 1. This was due to the fact that the original 
violet red bile plates were several days old 'frhen received. This 
had given the paracolon organisms time t o adapt to ferment lactose 
and turn the colonies pink, th erefore, they were picked as coli-
form colonies. 
Proteus was encountered in the feces of six sub jects alto-
gether. When using violet r ed bile and Endo plates in Series 1, 
Proteus became a nuisance organism in the cultur es from A.P. and 
T. S. because of its spreading charac t eristic. Th i s made it di ffi-
cul t to i solate lac t ose ferment i ng or ganisms from these plates. 
In Series 2, however , spreading was no pr oblem when using tergitol-
7 aga r because Prot eus colonies rema ined discrete. They r educed 
tr ipheny l t.etrazolium chlor ide t us E; i ving the same colonial 
appearance (red center with white periphery) as the paracolons 
a nd non-ls.ctose fermenting coloni es. Proteus wa s isolated from 
fou ,;. subjects of Series 2 . It appeared on the i.nitia l culture 
as vrell a s on e.ll subsequent cul t ures of B.G. and E.L. In t he 
cultur es of M.S. and D.D. it appeared after therapy and on the 
last day of treatment respectively. 
Pseudomonas was isolated from the initial cul t ure of D.D. 
but from none thereafter. This organism vlas not found in the 
cul t ures of any ot her sub j ects. 
Three of the sub jects ~hawed no change in type of organism. 
Two of these v1ere from the first series in which only coliform 
organisms v1ere being studied. The thi r d was M.C. who showed only 
paracolon organisms throughout the study of her fec a l specimens. 
The remaining cultures of this subject were curious in that no 
other organisms except paracolons appeared either durine; or after 
t hera:_Jy . 
In one subj ec t , L., the relative numbers of Escherichia 
increased during treatment and fell to approximately the original 
level after therapy. 'Ihis patient had Klebsiella s.nd paracolon 
organi sms in about equal numbers mixed with the Escherichia 
in the initia l fecal specimen. 
The cul t ures of the initial fecal spec imens of Series 2 
vrere of interest. By using t ergi tol-7 with triphenyl tetrazolium 
chloride, an assortment of organisms could be observed. Three 
of these initial specimens shovTed a single kind of organism, 
E. coli in two people and paracolons in the t hi r d. The remaining 
f ive initial specimens showed a mixture of Escherichia, Klebsiella, 
Pr oteuu and paracolon organisms wi~~ Escherichia usually predom-
ina t.ing . 
'Ihe assortment of organisms seen in the fecal specimens 
taken before treatment is in accordance with Parr's (24) observe.-
t .ions of the fecal flora of 100 normalpeople, including adults 
and children, who were no t under treatment. He concluded that: 
" ••••• there is great variability in the so-called 
normal coliform flora and in the flora of the same 
individual from day to day .R 
\fu ile most of our specimens were cultured within a few hours 
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t o 24 hours of the time they were taken, a few 1rrere held for several 
days before plating . Par r 's (22 , 2) ) work on the storage of 
human feces has shown in some instances a change from a predom-
inating Escherichia of fresh feces to a "lactose-degraded Aero-
bacter flora" (2)) in the same specimen after s~crage for a 
few weeks' time. In view of Parr's work it seemed possible 
that the delay in culturing mi ght. have affected the results of a 
few specimens although none 'frere over three days old when plated. 
Consequently two fecal specimens vrere held under refrigeration 
and plated every day to observe the results. Since the fecal 
swab was in a tube with 1 ml of buffered glycerol-saline and the 
1:2 dilution was made directly in the sa.me tube, the specimens 
were refrigerated in this manner. T'ne original plating shov1ed 
the presence of only !· coli in one specimen and !· coli mixed 
with a fe~6ther organisms in the other specimen. After nine 
successive days of culturing , there was essentially no change 
in either sp ecimen. tt was concluded that under the conditions 
of the present studies, the delay in culturing probably had no 
adverse effect on the results. 
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The limited number of biochemical reactions used in this 
study for the identification of the organisms was certai nly not 
sufficient t o identify them with precision. However, they have 
sufficed t o delimit the groups of coliform and paracolon organ-
isms that have appeared throughout the study. In fact in four 
subjects, A.P., T.S., D.D. and E.L., they have shown the emergence 
after treatment of a strain of Escherichia possib ly diffe rent 
from that found before tres.+.ment . T'ne cul tures of A. P. showed 
typ ica l !· coli before treatment . Later a few muc oid, non-mot ile 
organisms we re mixed Hith typical!· coli. In the cultures of 
T.S. the non-mucoid , non-mot ile Escherichia organisms found at 
the beginning of the study were c omp letely replaced by mucoid 
organisms from the fifth day of aureomycin administra tion until 
the end of the study of this subjec t. I n the cul tures of D.D. 
non-motile Escherichia 1,rere replaced by moti le Escherichia . '!he 
cultures of the l ast patient, E.L., had Es cherichia which utilized 
ci t rat e in t he initial specimen. In the last specimen this same 
variety of Escherichia was accompanied by typica l !• coli. 
\ ork done by Sears , Brownlee and Uchiyama (50) and by Sears 
and Br o1·mlee (29) sho1ved what they called "residen t" strains of 
_E; . coli beinE replaced temporar ily by " t rans i ent" s t rains or 
pe rmanently by different "re s ident• strains. Sears and his co-
workers compared their strains of organi sms serologically. They 
noticed that in some of their subjects , the change was so:netimes 
accompani ed by an int estinal disorder. However, they ~-;ere not 
able to pr ove the relationship between the i ntestina l disorder 
e.nd a change in "resident" E. coli. 
Because of the apparent changes in var iety of organisms 
show·n by biochemica l reactions , it was decided to make s.ome 
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studies of the antigenic properties of the Escherichia organisms 
from the pre sent series of subjects . Accordingly a project (26) 
is now in progress to study Escherichia strains isolated from 
subjects A.P., K.C., P .J., A.D. a.nd D.D. 
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Conclusions 
1. No resistant coliform organisms were isolated from the 
feces of four subjects following the oral administration of aureo-
mycin. 
2. A change of coliform flora occur red in the feces of 
seven of twelve subjects following oral administration of 
aureomycin. 
). A greatly var ied coliform flora was present in the 
s tools of eight subjects with apparently normal gastrointestinal 
t rac t s v.•ho were being treated with aur eomycin for various dis-
eases . 
4. In four of the subjects pre sented some of t he Escherichia 
organisms isolated after the oral administration of aureomycin 
appeared to be different from the ones isolated before the drug 
\.Ya s given. 
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Abstract 
Because of the i mportance in abdominal surgery of finding 
an antibiotic or comb ina tiona of antibiotics which will be 
effective in suppressing the fecal flora, many wo r kers have 
studied each new agent from this standpoint. Loh (1), in doing 
count s of organisms in the feces of normal humans during the 
oral administration of aureomycin, found a decrease in coliform 
bacteria in many of his subjects. This decrease was often fol-
lowed by a rise to or above pre-drug level. Tne question arose -
were resistant organisms emerging? Four of his subjects were 
s t udied for sensitivity to aureomycin of the coliform organisms. 
The minimum inhibitory concentration of aureomycin for 
Escherichia increased slightly from 0.78-).12 g/ml in two of 
the subjects but showed essentially no change remaining at a 
minimum inhibitory concentration of ).12 g/ ml throughout the 
study of the other two subjects. The slight variation \'las hardly 
more than that noticed in the control cul t ure. There 'appeared 
to be essentially no development of resistant organisms. 
During the course of these studies, the coliform population 
in t wo of Loh 1 s subjects changed from Escherichia before thera,y 
to Klebsiella during or directly after treatment and back to 
1 
Escherichia after the drug was stopped. In order to determine 
whether this mi ght be a common change during aureomycin therapy, 
eight more persons were studied. 
2 
The cultures of the fecal specimens of five of the eight 
subjects did show a decrease in numbers of Escherichia organisms 
during the oral administration of aureomycin. This was accompanied 
by an increase in numbers of Klebsiella and/or paracolon organisms 
with a subsequent rise in Escherichia numbers. One subject had 
too few cultures studied for definite conclusions to be made but 
those that were obtained suggested a similar shift. The cultures 
of one subject showed the opposite shift, an increase in Escherichia 
with a decrease in Klebsiella and paracolons and a return of 
Escherichia to about the or i ginal level. The specimens of one 
subjec t differed from the rest in that they contained nothing 
but paracolon organisms before, during and after the oral adminis-
tration of aureomycin. 
The initial cultures taken before administration of aureo-
mycin were of interest in that they varied so greatly . Escherichia 
predominated in most of these initial cultures and was the only 
kind of orga:rlsm isolated from two. Usually Escherichia was accom-
panied by Klebsiella or paracolons or both and in three subjects 
Prot eus also ap?eared. 
Escherichia organi sms had different biochemical reactions 
before and after therapy in four of the twelve subjects. This 
change was from non-mucoid to mucoid colonies in the cultures 
of two subjects, from non-motile to motile organisms in the cul-
tures of one subject and from a citrate utilizing Escherichia to 
a mixture of the same citrate utilizing variety plus Escherichia 
with typical biochemical reactions. 
This change in biochemical reactions suggested a possible 
anti ~enic change in the Escherichia organisms isolated before and ~ ,. 
after the administration of aureomycin. This possibility is being 
studied further. 
Conclusions 
1. No resistant c.oliform organisms were isolated from the 
feces of four subjects following the oral administration of aureo-
mycin . 
2. A change of coliform flora occurred in the feces of 
seven of twelve subjects following oral administration of aureo-
mycin. 
;>. A greatly varied coliform flora was present in the 
stools of eight subjects with apparently normal gastrointestinal 
tracts who were being treated with aureomycin for various diseases. 
4. In four of the subjects studied some of the Escherichia 
organisms isolated after the oral administration of aureomycin 
appeared to be different from the ones isolated before the drug 
was given . 
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